Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

James Ewing (1866-1943): "the chief"

A R Zantinga1, M J Coppes

  • 1Department of Cancer Biology, Cleveland Clinic Foundation, Ohio.

Medical and Pediatric Oncology
|January 1, 1993
PubMed
Summary

Reducing cancer mortality requires a multi-faceted approach, focusing on prevention, early detection, and timely treatment. Continuous state support for cancer research hospitals is crucial for advancing cancer care and improving patient outcomes.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and pharmacokinetics of temozolomide using a dose-escalation, metronomic schedule in recurrent paediatric brain tumours.

European journal of cancer (Oxford, England : 1990)·2006
Same author

Choroid plexus tumours.

British journal of cancer·2002
Same author

Treatment with nephrectomy only for small, stage I/favorable histology Wilms' tumor: a report from the National Wilms' Tumor Study Group.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
Same author

Chronic recurrent multifocal osteomyelitis: a rare disorder presenting as multifocal bone lesions.

Medical and pediatric oncology·2001
Same author

Adaptation of renal function after unilateral nephrectomy in children with renal tumors.

Pediatric nephrology (Berlin, Germany)·2001
Same author

Hematopoietic stem cell transplantation (HSCT) with a conditioning regimen of busulfan, cyclophosphamide, and etoposide for children with acute myelogenous leukemia (AML): a phase I study of the Pediatric Blood and Marrow Transplant Consortium.

Medical and pediatric oncology·2000

Area of Science:

  • Oncology
  • Public Health
  • Medical Research

Background:

  • Understanding cancer in humans necessitates direct study within the human subject.
  • Cancer mortality reduction is unlikely to stem from single "sensational" discoveries.